Argenx shrugs off myasthenia gravis threat from UCB as Vyvgart nears next potential launch fkansteiner Thu, 05/09/2024 – 16:40 More: Argenx shrugs off myasthenia gravis threat from UCB as Vyvgart nears next potential launch Source: fierce
read moreBayer’s Midol unveils PeriodTalk campaign to ramp up conversations, education about menstruation apark Thu, 05/09/2024 – 12:09 More: Bayer’s Midol unveils PeriodTalk campaign to ramp up conversations, education about menstruation Source: fierce
read morePfizer puts 74 Swiss jobs on chopping block as it folds Seagen into its cancer operations fkansteiner Thu, 05/09/2024 – 11:36 More: Pfizer puts 74 Swiss jobs on chopping block as it folds Seagen into its cancer operations Source: fierce
read moreAs Vyvanse generics bite, Takeda sets out on $900M restructuring plan zbecker Thu, 05/09/2024 – 11:28 More: As Vyvanse generics bite, Takeda sets out on 0M restructuring plan Source: fierce
read moreIn gene therapy race, bluebird leads Vertex in activating treatment centers but trails in patient starts kdunleavy Thu, 05/09/2024 – 11:15 More: In gene therapy race, bluebird leads Vertex in activating treatment centers but trails in patient starts Source: fierce
read moreAnticancer drugs will be responsible for 90% of nearly 612,000 predicted US cancer deaths in 2024 More: Oregon and Lantern collaborate to develop drug candidate for various cancer indications Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals